Advances in Gerontology

, Volume 8, Issue 1, pp 33–36 | Cite as

Community-Acquired Bacterial Pneumonia and Comorbidity in Elderly Patients

  • O. V. Fatenkov
  • T. M. Kuzmina
  • O. A. Rubanenko
  • G. N. Svetlova
  • A. V. Djubailo


We have analyzed the clinical course of pneumonia in 67 elderly patients (39 women and 28 men, the average age: 74.4 ± 5.2 years) with chronic heart failure and chronic obstructive pulmonary disease (COPD). The patients were divided into two groups: with COPD (group 1) and without COPD (group 2). Pharmacological treatment incorporating ampicillin and sulbactam was performed taking into account clinical laboratory indices (temperature, oxygen saturation, and levels of acute-phase proteins (ESRs)). The normalization of temperature and oxygen saturation was observed on day 3–4 in group 1 and on day 2 in group 2; normalization of leukocyte content and erythrocyte sedimentation rate was observed on day 12–13 and 7–8, respectively; and the acute phase indicators (C-reactive protein, fibrinogen) were normalized on day 7 and 5, respectively. Positive dynamics of chest X-ray analysis was observed on day 13 in patients of group 1 (the second control and the use of levofloxacin as alternative to the antibiotic previously used) and on day 8 in patients of group 2 (the first control).


pneumonia chronic obstructive pulmonary disease chronic heart failure comorbidity antibacterial therapy levofloxacin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bobylev, A.A., Rachina, S.A., Avdeev, S.N., Kozlov, R.S., and Dekhnich, N.N., Community-acquired pneumonia in elderly and very elderly patients, Pul’monologiya, 2015, vol. 3, pp. 261–276.Google Scholar
  2. 2.
    Dvoretskii, L.I., Community-acquired pneumonia in patients with chronic obstructive pulmonary disease, Prakt. Pul’monol., 2015, no. 2, pp. 17–24.Google Scholar
  3. 3.
    Kozlov, R.S., Sivaya, O.V., Krechikova, O.I., et al., Dynamics of resistance of Streptococcus pneumoniae to antibiotics in Russia over 1999–2009, Klin. Mikrobiol. Antimikrob., Khimioter., 2010, vol. 12, no. 4, pp. 329–341.Google Scholar
  4. 4.
    Rzhannikova, N.I. and Rzhannikova, A.N., Community-acquired pneumonia in the elderly: diagnosis at the outpatient stage, Akad. Zh. Zap. Sib., 2012, no. 3, pp. 25–27.Google Scholar
  5. 5.
    Chuchalin, A.G., Pneumonia as an actual medical problem of the 21th century, Pul’monologiya, 2015, no. 2, pp. 133–142.Google Scholar
  6. 6.
    Chuchalin, A.G., Sinopal’nikov, A.I., Kozlov, R.S., Avdeev, S.N., Tyurin, I.E., Rudnov, V.A., Rachina, S.A., and Fesenko, O.V., Russian Respiratory Society Interregional association on clinical microbiology and antimicrobial chemotherapy. Clinical guidelines on diagnosis, treatment and prevention of severe communityacquired pneumonia in adults, Pul’monologiya, 2014, no. 4, pp. 13–48.Google Scholar
  7. 7.
    Corrales-Medina, V.F., Musher, D.M., and Wells, G.A., Cardiac complications in patients with communityacquired pneumonia: incidence, timing, risk factors, and association with short-term mortality, Circulation, 2012, vol. 125, no. 6, pp. 773–781.CrossRefPubMedGoogle Scholar
  8. 8.
    Effing, T.W., Vercoulen, J.H., Bourbeau, J., et al., Definition of a COPD self-management intervention: International Expert Group consensus, Eur. Respir. J., 2016, vol. 48, no. 1, pp. 46–54.CrossRefPubMedGoogle Scholar
  9. 9.
    Griffin, A.T., Wiemken, T.L., and Arnold, F.W., Risk factors for cardiovascular events in hospitalized patients with community-acquired pneumonia, Int. J. Infect. Dis., 2014, vol. 17, pp. e1125–e1129.CrossRefGoogle Scholar
  10. 10.
    Mandal, P., Chalmers, J.D., Choudhury, G., et al., Vascular complications are associated with poor outcome in community-acquired pneumonia, Quart. J. Med., 2011, vol. 104, pp. 489–495.CrossRefGoogle Scholar
  11. 11.
    Sibila, O., Mortensen, E.M., Anzueto, A., et al., Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia, Eur. Respir. J., 2014, vol. 43, no. 1, pp. 36–42.CrossRefPubMedGoogle Scholar
  12. 12.
    Soriano, J.B. and Suissa, S., Ageing lungs and very elderly COPD: anytime and anywhere, Eur. Respir. J., 2016, vol. 47, pp. 379–381.CrossRefPubMedGoogle Scholar
  13. 13.
    Viasus, D., Garcia-Vidal, C., Manresa, F., et al., Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia, J. Infect., 2013, vol. 66, no. 1, pp. 27–33.CrossRefPubMedGoogle Scholar
  14. 14.
    Welte, T., Torres, A., and Nathwani, D., Clinical and economic burden of community-acquired pneumonia among adults in Europe, Thorax, 2012, vol. 67, no. 1, pp. 71–79.CrossRefPubMedGoogle Scholar
  15. 15.
    World Health Organization, Chronic Obstructive Pulmonary Disease (COPD), Fact sheet no. 315, Updated 2015. http// Scholar
  16. 16.
    World Health Organization, Chronic respiratory diseases, 2010. http// Scholar

Copyright information

© Pleiades Publishing, Ltd. 2018

Authors and Affiliations

  • O. V. Fatenkov
    • 1
  • T. M. Kuzmina
    • 1
  • O. A. Rubanenko
    • 1
  • G. N. Svetlova
    • 1
  • A. V. Djubailo
    • 1
  1. 1.Samara State Medical UniversitySamaraRussia

Personalised recommendations